Mineralocorticoid receptor antagonists in heart failure with preserved (and mildly reduced) ejection fraction: a comparative review of spironolactone and finerenone
Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure presentations and remains associated with substantial mortality, ranging from 15% at 1 year to nearly 75% within 5-10 years following hospitalization. Mineralocorticoid receptor antagonists (...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
PAGEPress Publications
2026-07-01
|
| Ráidu: | Global Cardiology |
| Fáttát: | |
| Liŋkkat: | https://www.globalcardiology.info/site/article/view/110 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|